Lee Biosolutions Inc, a leading biotech
company in the healthcare field serving the Global diagnostic industry, will expand into a new 40,786 square foot facility in Maryland Heights, a suburb of St. Louis, Missouri
The firm is a key manufacturer of high purity enzymes and related proteins that include tumor markers, cardiac markers, specialty diagnostic proteins for immunological diseases and biomarkers. The company is known internationally for developing some of the most successful formulations for research, diagnostic and therapeutic markets.
Company officials said the need for a new space is in response to its rising growth into new markets and increased demand for its products. Its new campus was previously home to KV Pharmaceuticals. The Increased analytical lab space is needed for Lee Bio's increased growth for bioanalytical research and development projects and its ever expanding bulk manufacturing requirements. The added capacity and resources will help the company achieve its projected growth through 2017.
Burton Lee, President/CEO said ,"With the rapid growth we have seen over the last few years, our current facility was not able to keep up with demand. The new building supports our strategic objective to further expand our product lines, increase our capacity on key contract manufacturing products requiring larger cGMP processing clean rooms and to create operational efficiencies to meet our clients requirements." The company plans on doubling its payroll by 2016.